Omalizumab for the treatment of severe persistent allergic asthma: a systematic review and economic evaluation

Background: Allergic asthma is a long-term disorder of the airways resulting from overexpression of immunoglobulin E (IgE) in response to environmental allergens. Patients with poorly controlled asthma are at high risk of exacerbations requiring additional treatment, including hospitalisations. Seve...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: G Norman, R Faria, F Paton, A Llewellyn, D Fox, S Palmer, I Clifton, J Paton, N Woolacott, C McKenna
Formato: Artigo
Lenguaje:Inglês
Publicado: NIHR Journals Library 2013-11-01
Colección:Health Technology Assessment
Materias:
adults
asthma
children
omalizumab
systematic review
Acceso en línea:https://doi.org/10.3310/hta17520
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares